Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005

Vaccine

Volumn 28, Issue 37, 2010, Pages 5973-5978

  Cui, Fuqiang ^a   Li, Li ^a   Hadler, Stephen C ^b   Wang, Fuzhen ^a   Zheng, Hui ^a   Chen, Yuansheng ^a   Gong, Xiaohong ^a   Hutin, Yvan J ^c   Cairns, K Lisa ^c   Liang, Xiaofeng ^a   Yang, Weizhong ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Birth dose; HBsAg; Hepatitis B; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ARTICLE; BIRTH RATE; BIRTHPLACE; CHILD; CHINA; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROPREVALENCE; ADOLESCENT; IMMUNIZATION; IMMUNOLOGY; INFANT; PRESCHOOL CHILD; PREVALENCE; STATISTICS AND NUMERICAL DATA; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; VACCINATION;

EID: 77955519052     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.111     Document Type: Article

References (21)

1. West D.J., Margolis H.S. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 1992, 11:866-874.
2. Xia G.L., Liu C.B., Cao H.L., Bi S.L., Zhan M.Y., Su C.A., et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D and E virus infections in China, 1992. Int Hepatol Commun 1996, 5:62-73.
3. Zhuang H. Epidemiology of hepatitis. Chin J Vaccines Immunization 2004, 10:180-181.
4. He J., Gu D., Wu X., Reynolds K., Duan X., Yao C., et al. Major causes of death among men and women in China. N Engl J Med 2005, 353:1124-1134.
5. Giammanco G., Li V.S., Mauro L., Bilancia G.G., Salemi I., Barone P., et al. Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy. Vaccine 1991, 9:747-750.
6. World Health Organization Hepatitis B vaccine, WHO position paper. WER 2009, 84:405-420.
7. Zhu X., Zhang X., Wang L. National EPI vaccination and hepatitis B vaccine coverage rate and the related factors: results from the 1999 nationwide survey. Chin J Vaccines Immunization 2000, 6:193-197.
8. Cui F.Q., Wang X.J., Cao L., Liang X., Lu Y., Hu Y., et al. Progress in hepatitis B prevention through universal infant immunization-China, 1997-2006. MMWR 2007, 56:441-445.
9. Liang X.F., Bi S.L., Yang W.Z., Wang L., Cui G., Cui F., et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009, 27:6550-6557.
10. Wang L., Li J., Chen H., Li F., Armstrong G.L., Nelson C., et al. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ 2007, 85:688-694.
11. Liang X.F., Bi S.L., Yang W.Z., Wang L., Cui G., Cui F., et al. Evaluation of the impact of hepatitis B vaccination among children born between 1992 and 2005 in China. J Infect Dis 2009, 200:39-47.
12. Korn E., Graubard B. Examples of differing weighted and unweighted estimates from a sample survey. Am Statistician 1995, 49:291.
13. Cui F.Q., Gaofin R. Immunization coverage and its determinants in children aged 12-23 months in Gansu, China. Vaccine 2007, 25:664-671.
14. Zhou Y., Wang H., Zheng J., Zhu X., Xia W., Hipgrave D., et al. Coverage of and influences on timely administration of hepatitis B vaccine birth dose in remote rural areas of the People's Republic of China. Am J Trop Med Hyg 2009, 81:869-874.
15. Wilson N., Ruff T.A., Rana B.J., Leydon J., Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine 2000, 18:3059-3066.
16. Lee C., Gong Y., Brok J., Boxall E.H., Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. Br Med J 2006, 332:328-336.
17. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006, 28:112-125.
18. Da Villa G., Romano L., Sepe A., Iorio R., Paribello N., Zappa A., et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007, 25:3133-3136.
19. Gupta S., Gupta R., Joshi Y.K., Singh S. Role of horizontal transmission in hepatitis B virus spread among household contacts in north India. Intervirology 2008, 51:7-13. Epub 2008 February 29.
20. Wendel S, Levi JE, Biagini S, Candotti D, Allain JP. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period 2008;48:1602-8.
21. Davaalkham D., Ojima T., Wiersma S., Lkhaguasuren T.S., Nymadawa P., Uehara R., et al. Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nationwide survey. J Epidemiol Community Health 2007, 61:578-584.